share_log

Biote Q4 2023 GAAP EPS $0.18 Beats $0.08 Estimate, Sales $45.703M Miss $45.740M Estimate

Biote Q4 2023 GAAP EPS $0.18 Beats $0.08 Estimate, Sales $45.703M Miss $45.740M Estimate

Biote 2023年第四季度GAAP每股收益0.18美元超過預期的0.08美元,銷售額低於4570.3萬美元的預期
Benzinga ·  03/12 16:13

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.08 by 125 percent. This is unchanged from the same period last year. The company reported quarterly sales of $45.703 million which missed the analyst consensus estimate of $45.740 million by 0.08 percent. This is a 2.74 percent increase over sales of $44.485 million the same period last year.

Biote(納斯達克股票代碼:BTMD)公佈的季度收益爲每股0.18美元,比分析師共識估計的0.08美元高出125%。這與去年同期相比沒有變化。該公司公佈的季度銷售額爲45703萬美元,比分析師普遍預期的4574.0萬美元低0.08%。這比去年同期的4,4485萬美元的銷售額增長了2.74%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論